- MB Bch BAO, MRCPI, PhD – Center of Cancer Medicine, University of Hong Kong
- Vice President of the Hong Kong Neuro-Oncology Society
- Professor Aya El Helali is a clinician scientist specializing in medical oncology and translational research. She is currently a faculty member at the Department of Clinical Oncology, University of Hong Kong, and serves as a co-chair of the HKU-HKSH Molecular Tumor Board (MTB).
- She obtained her MB BCh BAO with first-class honors and gold medals in Medicine and Surgery from the National University of Ireland Galway (2008) and earned her PhD from Queen’s University Belfast as a Sir Allen McClay Clinical Research Fellow, focusing on biomarker development. Her postdoctoral research explored adaptive immunity.
- Professor El Helali has contributed significantly to understanding the molecular characteristics of ovarian cancer and the potential impact on anti-angiogenic therapies. She also played a pivotal role in developing Hong Kong’s first-in-human phase I clinical trial, advancing personalized medicine through her collaboration with the HKU-HKSH MTB.
